As described above, the CDK4/6–cyclinD1 axis is often dysregulated in NPCs at all stages, so inhibition of the related activity represents a common target in primary, recurrent, and even metastatic NPC. This evidence concerns the gene CDK4 and nasopharyngeal carcinoma.